Blue Trust Inc. Reduces Holdings in Genpact Limited (NYSE:G)

Blue Trust Inc. trimmed its stake in Genpact Limited (NYSE:GFree Report) by 67.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,670 shares of the business services provider’s stock after selling 3,420 shares during the period. Blue Trust Inc.’s holdings in Genpact were worth $72,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. JPMorgan Chase & Co. lifted its position in Genpact by 192.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider’s stock valued at $122,701,000 after acquiring an additional 2,060,595 shares during the period. Los Angeles Capital Management LLC purchased a new position in Genpact during the 3rd quarter valued at about $19,779,000. Tandem Investment Advisors Inc. purchased a new position in Genpact during the 3rd quarter valued at about $17,025,000. Geode Capital Management LLC lifted its position in Genpact by 12.6% during the 3rd quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider’s stock valued at $148,142,000 after acquiring an additional 413,646 shares during the period. Finally, Empowered Funds LLC increased its stake in Genpact by 1,942.3% during the 4th quarter. Empowered Funds LLC now owns 325,379 shares of the business services provider’s stock valued at $13,975,000 after purchasing an additional 309,447 shares in the last quarter. 96.03% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

G has been the subject of a number of analyst reports. TD Cowen upgraded shares of Genpact from a “hold” rating to a “buy” rating and raised their price objective for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Jefferies Financial Group upgraded shares of Genpact from a “hold” rating to a “buy” rating and raised their price objective for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Robert W. Baird raised their price objective on shares of Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a research note on Friday, November 8th. Needham & Company LLC raised their price objective on shares of Genpact from $55.00 to $65.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Finally, Mizuho raised their price objective on shares of Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Six investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $48.44.

Read Our Latest Analysis on Genpact

Insider Activity at Genpact

In other news, SVP Piyush Mehta sold 12,000 shares of the company’s stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the transaction, the senior vice president now directly owns 151,182 shares in the company, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of the company’s stock in a transaction dated Friday, December 13th. The stock was sold at an average price of $44.60, for a total transaction of $606,560.00. Following the completion of the transaction, the chief executive officer now owns 267,404 shares in the company, valued at approximately $11,926,218.40. The trade was a 4.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.80% of the stock is owned by insiders.

Genpact Stock Performance

Shares of NYSE G opened at $53.21 on Monday. The firm has a 50 day moving average of $47.00 and a 200 day moving average of $42.88. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $9.38 billion, a price-to-earnings ratio of 18.73, a price-to-earnings-growth ratio of 1.84 and a beta of 1.20. Genpact Limited has a 12-month low of $30.23 and a 12-month high of $56.76.

Genpact (NYSE:GGet Free Report) last issued its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, research analysts anticipate that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 1.28%. The ex-dividend date of this dividend is Tuesday, March 11th. This is an increase from Genpact’s previous quarterly dividend of $0.15. Genpact’s payout ratio is 23.94%.

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.